Jack Phillips - Feb 1, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Feb 1, 2022
Transactions value $
-$11,909
Form type
4
Date filed
2/7/2022, 04:21 PM
Previous filing
Dec 10, 2021
Next filing
Mar 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +10K +8.54% $0.00 127K Feb 1, 2022 Direct F1
transaction AXDX Common Stock Sale -$11.9K -3.65K -2.88% $3.26 123K Feb 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -10K -25% $0.00 30K Feb 1, 2022 Common Stock 10K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.